Cargando…

Molecular Mechanisms to Control Post-Transplantation Hepatitis B Recurrence

Hepatitis B often progresses to decompensated liver cirrhosis requiring orthotopic liver transplantation (OLT). Although newer nucleos(t)ide analogues result in >90% viral and hepatitis activity control, severely decompensated patients still need OLT because of drug-resistant virus, acute exacerb...

Descripción completa

Detalles Bibliográficos
Autores principales:	Takaki, Akinobu, Yasunaka, Tetsuya, Yagi, Takahito
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4581205/ https://www.ncbi.nlm.nih.gov/pubmed/26263973 http://dx.doi.org/10.3390/ijms160817494

Ejemplares similares

Safe and cost-effective control of post-transplantation recurrence of hepatitis B
por: Takaki, Akinobu, et al.
Publicado: (2015)

Contradictory Immune Response in Post Liver Transplantation Hepatitis B and C
por: Takaki, Akinobu, et al.
Publicado: (2014)

Which patients respond best to hepatitis B vaccination after a hepatitis B virus-related liver transplantation?
por: Takaki, Akinobu, et al.
Publicado: (2013)

Safety and Efficacy of Small Bowel Examination by Capsule Endoscopy for Patients before Liver Transplantation
por: Seiji, Kawano, et al.
Publicado: (2017)

Corrigendum to “Safety and Efficacy of Small Bowel Examination by Capsule Endoscopy for Patients before Liver Transplantation”
por: Kawano, Seiji, et al.
Publicado: (2017)

Serum hepatitis B virus DNA before liver transplantation correlates with HBV reinfection rate even under successful low-dose hepatitis B immunoglobulin prophylaxis
por: Yasunaka, Tetsuya, et al.
Publicado: (2011)

Hepatic and Gastric Involvement in a Case of Systemic Sarcoidosis Presenting with Rupture of Esophageal Varices
por: Saito, Hiroaki, et al.
Publicado: (2017)

Enhancement of Programmed Death Ligand 2 on Hepatitis C Virus Infected Hepatocytes by Calcineurin Inhibitors
por: Koike, Kazuko, et al.
Publicado: (2015)

Molecular Mechanisms and New Treatment Strategies for Non-Alcoholic Steatohepatitis (NASH)
por: Takaki, Akinobu, et al.
Publicado: (2014)

Predictive impact of polymorphism of PNPLA3 on HCC development after interferon therapy in Japanese patients with chronic hepatitis C
por: Moritou, Yuki, et al.
Publicado: (2013)

A subclinical high tricuspid regurgitation pressure gradient independent of the mean pulmonary artery pressure is a risk factor for the survival after living donor liver transplantation
por: Saragai, Yosuke, et al.
Publicado: (2018)

Prevention and Treatment of Recurrent Hepatitis B after Liver Transplantation
por: Maiwall, Rakhi, et al.
Publicado: (2016)

Reactivation of hepatitis B after liver transplantation: Current knowledge, molecular mechanisms and implications in management
por: Chauhan, Ranjit, et al.
Publicado: (2018)

Quality of life among patients with autoimmune hepatitis in remission: A comparative study
por: Takahashi, Atsushi, et al.
Publicado: (2020)

Hepatitis C Recurrence after Orthotopic Liver Transplantation: Mechanisms and Management
por: Kakati, Bobby, et al.
Publicado: (2014)

Symptoms and health-related quality of life in Japanese patients with primary biliary cholangitis
por: Yagi, Minami, et al.
Publicado: (2018)

Significance of Hepatitis B Recurrence in Liver Transplantation Recipients
por: Chou, Hong-Shiue, et al.
Publicado: (2020)

The management of post-transplantation recurrence of hepatocellular carcinoma
por: Rajendran, Luckshi, et al.
Publicado: (2022)

The impact of immunosuppressant therapy on the recurrence of hepatitis C post-liver transplantation
por: Albekairy, Abdulkareem M., et al.
Publicado: (2018)

Recurrence of hepatitis C after liver transplantation
por: Vinaixa, Carmen, et al.
Publicado: (2013)

Prophylaxis against Recurrence in Liver Transplantation Patients with Hepatitis B Virus: What is New?
por: Harmancı, Özgür, et al.
Publicado: (2014)

Therapeutic strategies for post-transplant recurrence of hepatocellular carcinoma
por: Sposito, Carlo, et al.
Publicado: (2022)

Deriving and understanding the risk of post-transplant recurrence of nephrotic syndrome in the light of current molecular and genetic advances
por: Bierzynska, Agnieszka, et al.
Publicado: (2017)

L-Carnitine Prevents Progression of Non-Alcoholic Steatohepatitis in a Mouse Model with Upregulation of Mitochondrial Pathway
por: Ishikawa, Hisashi, et al.
Publicado: (2014)

Prevention and treatment of recurrent Hepatitis B after liver transplantation: the current role of nucleoside and nucleotide analogues
por: Schreibman, Ian R, et al.
Publicado: (2006)

Rational Basis for Optimizing Short and Long-term Hepatitis B Virus Prophylaxis Post Liver Transplantation: Role of Hepatitis B Immune Globulin
por: Roche, Bruno, et al.
Publicado: (2015)

Hepatic Resection for Hepatocellular Carcinoma in the Era of Molecular-targeted Agents and Immune Checkpoint Inhibitors in Japan
por: Taketomi, Akinobu
Publicado: (2021)

Immunoglobulin, nucleos(t)ide analogues and hepatitis B virus recurrence after liver transplant: A meta‐analysis
por: Lai, Quirino, et al.
Publicado: (2021)

Insufficiency of phosphatidylethanolamine N-methyltransferase is risk for lean non-alcoholic steatohepatitis
por: Nakatsuka, Atsuko, et al.
Publicado: (2016)

Molecular Mechanisms during Hepatitis B Infection and the Effects of the Virus Variability
por: Campos-Valdez, Marina, et al.
Publicado: (2021)

Glecaprevir/pibrentasvir + sofosbuvir for post-liver transplant recurrent hepatitis C virus treatment
por: Arora, Rishi, et al.
Publicado: (2023)

Is Hepatitis B Immunoglobulin Necessary in Prophylaxis of Hepatitis B Recurrence after Liver Transplantation? A Meta-Analysis
por: Wang, Peijie, et al.
Publicado: (2014)

Recurrence of Hepatitis B Infection in Liver Transplant Patients Receiving Long-Term Hepatitis B Immunoglobulin Prophylaxis
por: Beckebaum, Susanne, et al.
Publicado: (2018)

State of the art treatment of hepatitis B virus hepatocellular carcinoma and the role of hepatitis B surface antigen post‐liver transplantation and resection
por: Schemmer, Peter, et al.
Publicado: (2021)

Acquired partial lipoatrophy as graft-versus-host disease and treatment with metreleptin: two case reports
por: Shibata, Yusuke, et al.
Publicado: (2018)

Molecular mechanisms of hepatic apoptosis
por: Wang, K
Publicado: (2014)

Fibrosing cholestatic hepatitis C in post-transplant adult recipients of liver transplantation
por: Hori, Tomohide, et al.
Publicado: (2016)

Treatment of Recurrent Hepatitis C Genotype-4 Post-Liver Transplantation with Sofosbuvir plus Simeprevir
por: Ascha, Mustafa, et al.
Publicado: (2015)

New Insights in Mechanisms and Therapeutics for Short- and Long-Term Impacts of Hepatic Ischemia Reperfusion Injury Post Liver Transplantation
por: Liu, Hui, et al.
Publicado: (2021)

Serial Changes of Serum Growth Factor Levels and Liver Regeneration after Partial Hepatectomy in Healthy Humans
por: Matsumoto, Kazuyuki, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_3he7hhd8rqrqvtd8bcvtlg5ars